Longitudinal Micro-ultrasound Assessment of the Ob/ob Mouse Model: Evaluation of Cardiovascular, Renal and Hepatic Parameters

Overview

Journal Int J Obes (Lond)

Specialty Endocrinology

Date 2017 Sep 9

PMID 28883542

Citations 5

Authors

N Di Lascio

C Kusmic

F Stea

F Lenzarini

C Barsanti

A Leloup

F Faita

Affiliations

Soon will be listed here.

Abstract

Background/objectives: Obesity is reaching epidemic proportions and is associated with increased risk factors for cardiovascular disease. Leptin-deficient mice (ob/ob) are widely employed to investigate obesity. Aim of this study was to provide a micro-ultrasound (μUS) longitudinal evaluation of the ob/ob mouse model in terms of cardiovascular effects, consequences for renal microcirculation and liver fat accumulation.

Subjects/methods: Sixteen wild-type (wt) and eleven ob/ob male mice were studied at 8 (T) and 25 (T) weeks of age with a μUS system (Vevo2100) and B-mode and Doppler images were acquired. Cardiac output (CO), ejection fraction (EF), stroke volume (SV), fractional shortening (FS) and E/A ratio were measured from cardiac images. Mean diameter (Dm, Dm), relative distension (relD and relD) and pulse wave velocity (PWV and PWV) were obtained for both abdominal aorta and common carotid. As regards renal microcirculation, renal resistivity and pulsatility index (RI and PI) were assessed. The ratio between grey levels related to liver and kidney (Steato-Score) was used as index of hepatic steatosis.

Results: At T, ob/ob mice showed reduced SV, EF, CO and relD values and increased LVmass, PWV, RI, PI and Steato-score measurements. The same comparison repeated at T highlighted similar results for SV, EF, CO, RI, PI and Steato-Score; furthermore, obese mice showed reduced Dm and Dm measurements in comparison with lean controls. The longitudinal analysis showed an increase in LVmass and Dm and a reduction of FS, EF, CO, relD and relD for wt animals, while no differences were found for the ob/ob group.

Conclusions: ob/ob mice presented a premature cardiac dysfunction without a further age-related deterioration and a reduction in the abdominal aorta and carotid artery mean diameter in adult age. The proposed analysis can represent a valid approach for longitudinal studies aimed at testing new therapeutic strategies or for characterizing other mouse models.

Citing Articles

Integrated Ultrasound Characterization of the Diet-Induced Obesity (DIO) Model in Young Adult c57bl/6j Mice: Assessment of Cardiovascular, Renal and Hepatic Changes.

Gargiulo S, Barone V, Bonente D, Tamborrino T, Inzalaco G, Gherardini L J Imaging. 2024; 10(9).

PMID: 39330437 PMC: 11433005. DOI: 10.3390/jimaging10090217.

S100A9 as a Key Myocardial Injury Factor Interacting with ATP5 Exacerbates Mitochondrial Dysfunction and Oxidative Stress in Sepsis-Induced Cardiomyopathy.

Pei H, Qu J, Chen J, Zhao G, Lu Z J Inflamm Res. 2024; 17:4483-4503.

PMID: 39006491 PMC: 11246037. DOI: 10.2147/JIR.S457340.

New Mouse Models of Roux-en Y Gastric Bypass and One Anastomosis Gastric Bypass for Type 2 Diabetes.

Yu J, Zhang H, Liu Q, Li H, Wu L, Qi T Obes Surg. 2023; 33(10):3163-3176.

PMID: 37635165 DOI: 10.1007/s11695-023-06768-z.

Protective Effect of Edaravone Against Oxidative Stress in C2C12 Myoblast and Impairment of Skeletal Muscle Regeneration Exposed to Ischemic Injury in Ob/ob Mice.

Nakanishi T, Tsujii M, Asano T, Iino T, Sudo A Front Physiol. 2020; 10:1596.

PMID: 32009986 PMC: 6974450. DOI: 10.3389/fphys.2019.01596.

The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.

Habibi J, Aroor A, Das N, Manrique-Acevedo C, Johnson M, Hayden M Cardiovasc Diabetol. 2019; 18(1):40.

PMID: 30909895 PMC: 6432760. DOI: 10.1186/s12933-019-0847-8.

References

Feng J, Khir A . Determination of wave speed and wave separation in the arteries using diameter and velocity. J Biomech. 2009; 43(3):455-62. DOI: 10.1016/j.jbiomech.2009.09.046. View

Le M, Jamrozik K, Davis T, Norman P . Negative association between infra-renal aortic diameter and glycaemia: the Health in Men Study. Eur J Vasc Endovasc Surg. 2007; 33(5):599-604. DOI: 10.1016/j.ejvs.2006.12.017. View

Mascareno E, Beckles D, Dhar-Mascareno M, Siddiqui M . Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide. Vascul Pharmacol. 2009; 51(2-3):198-204. PMC: 2747368. DOI: 10.1016/j.vph.2009.06.005. View

Esser N, Legrand-Poels S, Piette J, Scheen A, Paquot N . Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014; 105(2):141-50. DOI: 10.1016/j.diabres.2014.04.006. View

Artz N, Hines C, Brunner S, Agni R, Kuhn J, Roldan-Alzate A . Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse. Invest Radiol. 2012; 47(10):603-10. PMC: 3491646. DOI: 10.1097/RLI.0b013e318261fad0. View

Takahashi Y, Soejima Y, Fukusato T . Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2012; 18(19):2300-8. PMC: 3353364. DOI: 10.3748/wjg.v18.i19.2300. View

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J . Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372(6505):425-32. DOI: 10.1038/372425a0. View

Fabbrini E, Sullivan S, Klein S . Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2009; 51(2):679-89. PMC: 3575093. DOI: 10.1002/hep.23280. View

Buchanan J, Mazumder P, Hu P, Chakrabarti G, Roberts M, Yun U . Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology. 2005; 146(12):5341-9. DOI: 10.1210/en.2005-0938. View

10.

Gabbay E, Slotki I, Shavit L . Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease. BMC Nephrol. 2015; 16:133. PMC: 4528361. DOI: 10.1186/s12882-015-0137-y. View

11.

Hayashi K, Kanda T, Homma K, Tokuyama H, Okubo K, Takamatsu I . Altered renal microvascular response in Zucker obese rats. Metabolism. 2002; 51(12):1553-61. DOI: 10.1053/meta.2002.36311. View

12.

Semeniuk L, Severson D, Kryski A, Swirp S, Molkentin J, Duff H . Time-dependent systolic and diastolic function in mice overexpressing calcineurin. Am J Physiol Heart Circ Physiol. 2002; 284(2):H425-30. DOI: 10.1152/ajpheart.00546.2002. View

13.

Sikka G, Yang R, Reid S, Benjo A, Koitabashi N, Camara A . Leptin is essential in maintaining normal vascular compliance independent of body weight. Int J Obes (Lond). 2009; 34(1):203-6. DOI: 10.1038/ijo.2009.208. View

14.

Poirier P, Giles T, Bray G, Hong Y, Stern J, Pi-Sunyer F . Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition,.... Circulation. 2005; 113(6):898-918. DOI: 10.1161/CIRCULATIONAHA.106.171016. View

15.

Laurent S, Cockcroft J, van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D . Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006; 27(21):2588-605. DOI: 10.1093/eurheartj/ehl254. View

16.

Mancini M, Prinster A, Annuzzi G, Liuzzi R, Giacco R, Medagli C . Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy. Metabolism. 2009; 58(12):1724-30. DOI: 10.1016/j.metabol.2009.05.032. View

17.

Weisbrod R, Shiang T, Al Sayah L, Fry J, Bajpai S, Reinhart-King C . Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension. 2013; 62(6):1105-10. PMC: 3951434. DOI: 10.1161/HYPERTENSIONAHA.113.01744. View

18.

Wong C, OMoore-Sullivan T, Leano R, Byrne N, Beller E, Marwick T . Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004; 110(19):3081-7. DOI: 10.1161/01.CIR.0000147184.13872.0F. View

19.

Westergren H, Gronros J, Heinonen S, Miliotis T, Jennbacken K, Sabirsh A . Impaired Coronary and Renal Vascular Function in Spontaneously Type 2 Diabetic Leptin-Deficient Mice. PLoS One. 2015; 10(6):e0130648. PMC: 4476758. DOI: 10.1371/journal.pone.0130648. View

20.

Stapleton P, James M, Goodwill A, Frisbee J . Obesity and vascular dysfunction. Pathophysiology. 2008; 15(2):79-89. PMC: 2593649. DOI: 10.1016/j.pathophys.2008.04.007. View